{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:34:03Z","timestamp":1782488043152,"version":"3.54.5"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["97-02-158-39143"],"award-info":[{"award-number":["97-02-158-39143"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12974-019-1509-1","type":"journal-article","created":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T13:02:22Z","timestamp":1559394142000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["The antidepressant effects of GM-CSF are mediated by the reduction of TLR4\/NF-\u0138B-induced IDO expression"],"prefix":"10.1186","volume":"16","author":[{"given":"Sara","family":"Hemmati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Amin","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razieh","family":"Mohammad Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Yousefi-Manesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8001-5565","authenticated-orcid":false,"given":"Ahmad Reza","family":"Dehpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,1]]},"reference":[{"issue":"7","key":"1509_CR1","doi-asserted-by":"publisher","first-page":"732","DOI":"10.2174\/1570159X14666151208113700","volume":"14","author":"O Kohler","year":"2016","unstructured":"Kohler O, et al. Inflammation in depression and the potential for anti-inflammatory treatment. Current neuropharmacology. 2016;14(7):732\u201342.","journal-title":"Current neuropharmacology"},{"key":"1509_CR2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2147\/PPA.S29716","volume":"6","author":"KS Al-Harbi","year":"2012","unstructured":"Al-Harbi KS. Treatment-resistant depression: therapeutic trends, challenges, and future directions. Patient preference and adherence. 2012;6:369\u201388.","journal-title":"Patient preference and adherence"},{"issue":"1","key":"1509_CR3","first-page":"56","volume":"47","author":"GF Oxenkrug","year":"2010","unstructured":"Oxenkrug GF. Tryptophan kynurenine metabolism as a common mediator of genetic and environmental impacts in major depressive disorder: the serotonin hypothesis revisited 40 years later. The Israel journal of psychiatry and related sciences. 2010;47(1):56\u201363.","journal-title":"The Israel journal of psychiatry and related sciences"},{"issue":"11","key":"1509_CR4","doi-asserted-by":"publisher","first-page":"21328","DOI":"10.3390\/ijms141121328","volume":"14","author":"L Kubicova","year":"2013","unstructured":"Kubicova L, Hadacek F, Chobot V. Quinolinic acid: neurotoxin or oxidative stress modulator? Int J Mol Sci. 2013;14(11):21328\u201338.","journal-title":"Int J Mol Sci"},{"issue":"36","key":"1509_CR5","doi-asserted-by":"publisher","first-page":"5890","DOI":"10.2174\/138161212803523554","volume":"18","author":"TM Michel","year":"2012","unstructured":"Michel TM, Pulschen D, Thome J. The role of oxidative stress in depressive disorders. Curr Pharm Des. 2012;18(36):5890\u20139.","journal-title":"Curr Pharm Des"},{"issue":"2","key":"1509_CR6","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2174\/1570159X11666131120230309","volume":"12","author":"S Salim","year":"2014","unstructured":"Salim S. Oxidative stress and psychological disorders. Curr Neuropharmacol. 2014;12(2):140\u20137.","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"1509_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.2337\/db06-0617","volume":"56","author":"SA Sarkar","year":"2007","unstructured":"Sarkar SA, et al. Induction of indoleamine 2,3-dioxygenase by interferon-gamma in human islets. Diabetes. 2007;56(1):72\u20139.","journal-title":"Diabetes"},{"issue":"4","key":"1509_CR8","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/jb\/mvj072","volume":"139","author":"H Fujigaki","year":"2006","unstructured":"Fujigaki H, et al. The signal transducer and activator of transcription 1alpha and interferon regulatory factor 1 are not essential for the induction of indoleamine 2,3-dioxygenase by lipopolysaccharide: involvement of p38 mitogen-activated protein kinase and nuclear factor-kappaB pathways, and synergistic effect of several proinflammatory cytokines. J Biochem. 2006;139(4):655\u201362.","journal-title":"J Biochem"},{"issue":"5","key":"1509_CR9","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/sj.mp.4002148","volume":"14","author":"JC O'Connor","year":"2009","unstructured":"O'Connor JC, et al. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Molecular psychiatry. 2009;14(5):511\u201322.","journal-title":"Molecular psychiatry"},{"key":"1509_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1742-2094-7-43","volume":"7","author":"X Fu","year":"2010","unstructured":"Fu X, et al. Central administration of lipopolysaccharide induces depressive-like behavior in vivo and activates brain indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures. J Neuroinflammation. 2010;7:43.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"1509_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0304-3940(83)90115-5","volume":"38","author":"R Schwarcz","year":"1983","unstructured":"Schwarcz R, Kohler C. Differential vulnerability of central neurons of the rat to quinolinic acid. Neurosci Lett. 1983;38(1):85\u201390.","journal-title":"Neurosci Lett"},{"issue":"1","key":"1509_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12974-016-0590-y","volume":"13","author":"JM Parrott","year":"2016","unstructured":"Parrott JM, Redus L, O\u2019Connor JC. Kynurenine metabolic balance is disrupted in the hippocampus following peripheral lipopolysaccharide challenge. Journal of Neuroinflammation. 2016;13(1):124.","journal-title":"Journal of Neuroinflammation"},{"key":"1509_CR13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.bbr.2015.04.017","volume":"288","author":"Y Xu","year":"2015","unstructured":"Xu Y, et al. Inflammation and increased IDO in hippocampus contribute to depression-like behavior induced by estrogen deficiency. Behavioural Brain Research. 2015;288:71\u20138.","journal-title":"Behavioural Brain Research"},{"issue":"1","key":"1509_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11011-008-9118-1","volume":"24","author":"M Maes","year":"2009","unstructured":"Maes M, et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metabolic Brain Disease. 2009;24(1):27\u201353.","journal-title":"Metabolic Brain Disease"},{"issue":"11","key":"1509_CR15","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1177\/0271678X16660983","volume":"36","author":"DS Shang","year":"2016","unstructured":"Shang DS, et al. Intracerebral GM-CSF contributes to transendothelial monocyte migration in APP\/PS1 Alzheimer's disease mice. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 2016;36(11):1978\u201391.","journal-title":"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism"},{"issue":"1","key":"1509_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/ejn.13105","volume":"43","author":"JK Theoret","year":"2016","unstructured":"Theoret JK, et al. Granulocyte macrophage colony-stimulating factor treatment results in recovery of motor function after white matter damage in mice. Eur J Neurosci. 2016;43(1):17\u201324.","journal-title":"Eur J Neurosci"},{"issue":"1-2","key":"1509_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2013.10.009","volume":"265","author":"LM Kosloski","year":"2013","unstructured":"Kosloski LM, et al. GM-CSF induces neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated mice. J Neuroimmunol. 2013;265(1-2):1\u201310.","journal-title":"J Neuroimmunol"},{"issue":"5","key":"1509_CR18","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1111\/ejn.14106","volume":"48","author":"AL Bombeiro","year":"2018","unstructured":"Bombeiro AL, Pereira BTN, de Oliveira ALR. Granulocyte-macrophage colony-stimulating factor improves mouse peripheral nerve regeneration following sciatic nerve crush. Eur J Neurosci. 2018;48(5):2152\u201364.","journal-title":"Eur J Neurosci"},{"key":"1509_CR19","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/srep00697","volume":"2","author":"M Krieger","year":"2012","unstructured":"Krieger M, et al. The hematopoietic cytokine granulocyte-macrophage colony stimulating factor is important for cognitive functions. Scientific Reports. 2012;2:697.","journal-title":"Scientific Reports"},{"issue":"12","key":"1509_CR20","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1002\/glia.20853","volume":"57","author":"AK Mausberg","year":"2009","unstructured":"Mausberg AK, Jander S, Reichmann G. Intracerebral granulocyte-macrophage colony-stimulating factor induces functionally competent dendritic cells in the mouse brain. Glia. 2009;57(12):1341\u201350.","journal-title":"Glia"},{"issue":"1","key":"1509_CR21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/sj.jcbfm.9600496","volume":"28","author":"WR Schabitz","year":"2008","unstructured":"Schabitz WR, et al. A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF). J Cereb Blood Flow Metab. 2008;28(1):29\u201343.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"1509_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/brb3.11","volume":"1","author":"ME Choudhury","year":"2011","unstructured":"Choudhury ME, et al. A cytokine mixture of GM-CSF and IL-3 that induces a neuroprotective phenotype of microglia leading to amelioration of (6-OHDA)-induced Parkinsonism of rats. Brain and behavior. 2011;1(1):26\u201343.","journal-title":"Brain and behavior"},{"issue":"4","key":"1509_CR23","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/(SICI)1098-1136(199906)26:4<344::AID-GLIA8>3.0.CO;2-L","volume":"26","author":"SM Liva","year":"1999","unstructured":"Liva SM, et al. Signal transduction pathways induced by GM-CSF in microglia: significance in the control of proliferation. Glia. 1999;26(4):344\u201352.","journal-title":"Glia"},{"issue":"6","key":"1509_CR24","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/jnr.23205","volume":"91","author":"J Legacy","year":"2013","unstructured":"Legacy J, et al. Granulocyte macrophage colony-stimulating factor promotes regeneration of retinal ganglion cells in vitro through a mammalian target of rapamycin-dependent mechanism. J Neurosci Res. 2013;91(6):771\u20139.","journal-title":"J Neurosci Res"},{"issue":"2","key":"1509_CR25","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1007\/s12035-013-8550-3","volume":"49","author":"JK Choi","year":"2014","unstructured":"Choi JK, et al. Granulocyte macrophage colony-stimulating factor shows anti-apoptotic activity via the PI3K-NF-kappaB-HIF-1alpha-survivin pathway in mouse neural progenitor cells. Mol Neurobiol. 2014;49(2):724\u201333.","journal-title":"Mol Neurobiol"},{"issue":"3","key":"1509_CR26","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3109\/00365540903405768","volume":"42","author":"JC Schefold","year":"2010","unstructured":"Schefold JC, et al. Treatment with granulocyte-macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock. Scand J Infect Dis. 2010;42(3):164\u201371.","journal-title":"Scand J Infect Dis"},{"issue":"Pt 11","key":"1509_CR27","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1093\/brain\/120.11.2083","volume":"120","author":"RN McLay","year":"1997","unstructured":"McLay RN, et al. Granulocyte-macrophage colony-stimulating factor crosses the blood--brain and blood--spinal cord barriers. Brain. 1997;120(Pt 11):2083\u201391.","journal-title":"Brain"},{"key":"1509_CR28","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jneuroim.2014.11.002","volume":"0","author":"ML Kelso","year":"2015","unstructured":"Kelso ML, et al. Neuroprotective Activities of Granulocyte-Macrophage Colony Stimulating Factor Following Controlled Cortical Impact. Journal of neuroimmunology. 2015;0:162\u201373.","journal-title":"Journal of neuroimmunology"},{"key":"1509_CR29","doi-asserted-by":"crossref","unstructured":"Can, A., et al., The mouse forced swim test. Journal of visualized experiments : JoVE, 2012(59): p. e3638-e3638.","DOI":"10.3791\/3638-v"},{"key":"1509_CR30","doi-asserted-by":"crossref","unstructured":"Yankelevitch-Yahav R, et al. The forced swim test as a model of depressive-like behavior. Journal of visualized experiments : JoVE. 2015;(97):52587.","DOI":"10.3791\/52587"},{"key":"1509_CR31","doi-asserted-by":"publisher","unstructured":"Jenabian M-A, et al. Correction: distinct tryptophan catabolism and Th17\/Treg balance in HIV progressors and elite controllers. PLOS ONE. 2014;9(1). https:\/\/doi.org\/10.1371\/annotation\/11698dd2-0bc1-4fe0-ad92-b161b5594e81 .","DOI":"10.1371\/annotation\/11698dd2-0bc1-4fe0-ad92-b161b5594e81"},{"issue":"2","key":"1509_CR32","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1023\/A:1023260610025","volume":"13","author":"\u00d8 Langsrud","year":"2003","unstructured":"Langsrud \u00d8. ANOVA for unbalanced data: use type II instead of type III sums of squares. Statistics and Computing. 2003;13(2):163\u20137.","journal-title":"Statistics and Computing"},{"issue":"4","key":"1509_CR33","first-page":"552","volume":"29","author":"MJ Blanca","year":"2017","unstructured":"Blanca MJ, et al. Non-normal data: Is ANOVA still a valid option? Psicothema. 2017;29(4):552\u20137.","journal-title":"Psicothema"},{"issue":"8","key":"1509_CR34","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/j.bbi.2011.06.006","volume":"25","author":"MA Erickson","year":"2011","unstructured":"Erickson MA, Banks WA. Cytokine and chemokine responses in serum and brain after single and repeated injections of lipopolysaccharide: multiplex quantification with path analysis. Brain Behav Immun. 2011;25(8):1637\u201348.","journal-title":"Brain Behav Immun"},{"issue":"6","key":"1509_CR35","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1172\/JCI117274","volume":"93","author":"G Tiegs","year":"1994","unstructured":"Tiegs G, et al. Potentiation by granulocyte macrophage colony-stimulating factor of lipopolysaccharide toxicity in mice. J Clin Invest. 1994;93(6):2616\u201322.","journal-title":"J Clin Invest"},{"issue":"11","key":"1509_CR36","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1172\/JCI25681","volume":"115","author":"JA Reed","year":"2005","unstructured":"Reed JA, et al. GM-CSF action in the CNS decreases food intake and body weight. The Journal of clinical investigation. 2005;115(11):3035\u201344.","journal-title":"The Journal of clinical investigation"},{"issue":"1","key":"1509_CR37","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1182\/blood-2002-12-3753","volume":"102","author":"K Ebner","year":"2003","unstructured":"Ebner K, et al. GMCSF activates NF-kappaB via direct interaction of the GMCSF receptor with IkappaB kinase beta. Blood. 2003;102(1):192\u20139.","journal-title":"Blood"},{"issue":"1","key":"1509_CR38","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/1742-2094-9-268","volume":"9","author":"Bijay Parajuli","year":"2012","unstructured":"Parajuli, B., et al., GM-CSF increases LPS-induced production of proinflammatory mediators via upregulation of TLR4 and CD14 in murine microglia. Journal of neuroinflammation, 2012. 9: p. 268-268.","journal-title":"Journal of Neuroinflammation"},{"key":"1509_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.clim.2017.12.002","volume":"188","author":"J Knoop","year":"2018","unstructured":"Knoop J, et al. GM-CSF producing autoreactive CD4(+) T cells in type 1 diabetes. Clin Immunol. 2018;188:23\u201330.","journal-title":"Clin Immunol"},{"key":"1509_CR40","first-page":"Cd008538","volume":"11","author":"L Roth","year":"2011","unstructured":"Roth L, et al. Sargramostim (GM-CSF) for induction of remission in Crohn\u2019s disease. Cochrane Database Syst Rev. 2011;11:Cd008538.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4 Suppl 98","key":"1509_CR41","first-page":"39","volume":"34","author":"AB Avci","year":"2016","unstructured":"Avci AB, Feist E, Burmester GR. Targeting GM-CSF in rheumatoid arthritis. Clin Exp Rheumatol. 2016;34(4 Suppl 98):39\u201344.","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"1509_CR42","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.it.2015.08.004","volume":"36","author":"AL Croxford","year":"2015","unstructured":"Croxford AL, Spath S, Becher B. GM-CSF in Neuroinflammation: Licensing Myeloid Cells for Tissue Damage. Trends Immunol. 2015;36(10):651\u201362.","journal-title":"Trends Immunol"},{"issue":"1","key":"1509_CR43","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1089\/jir.2006.26.53","volume":"26","author":"KA Shirey","year":"2006","unstructured":"Shirey KA, et al. Upregulation of IFN-\u03b3 Receptor Expression by Proinflammatory Cytokines Influences IDO Activation in Epithelial Cells. Journal of Interferon & Cytokine Research. 2006;26(1):53\u201362.","journal-title":"Journal of Interferon & Cytokine Research"},{"issue":"3","key":"1509_CR44","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.neures.2008.12.003","volume":"63","author":"M Hoshi","year":"2009","unstructured":"Hoshi M, et al. Marked increases in hippocampal neuron indoleamine 2, 3-dioxygenase via IFN-gamma-independent pathway following transient global ischemia in mouse. Neurosci Res. 2009;63(3):194\u20138.","journal-title":"Neurosci Res"},{"issue":"5","key":"1509_CR45","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.immuni.2016.10.026","volume":"45","author":"B Becher","year":"2016","unstructured":"Becher B, Tugues S, Greter M. GM-CSF: from growth factor to central mediator of tissue inflammation. Immunity. 2016;45(5):963\u201373.","journal-title":"Immunity"},{"issue":"7","key":"1509_CR46","doi-asserted-by":"publisher","first-page":"e23025","DOI":"10.1371\/journal.pone.0023025","volume":"6","author":"HJ Khameneh","year":"2011","unstructured":"Khameneh HJ, et al. GM-CSF Signalling boosts dramatically IL-1 production. PLOS ONE. 2011;6(7):e23025.","journal-title":"PLOS ONE"},{"issue":"3","key":"1509_CR47","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.immuni.2015.08.010","volume":"43","author":"AL Croxford","year":"2015","unstructured":"Croxford AL, et al. The cytokine GM-CSF drives the inflammatory signature of CCR2+ monocytes and licenses autoimmunity. Immunity. 2015;43(3):502\u201314.","journal-title":"Immunity"},{"issue":"8","key":"1509_CR48","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.pnpbp.2011.07.004","volume":"35","author":"Y Wang","year":"2011","unstructured":"Wang Y, et al. LPS inhibits the effects of fluoxetine on depression-like behavior and hippocampal neurogenesis in rats. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(8):1831\u20135.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1509_CR49","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.psyneuen.2018.05.026","volume":"95","author":"E Haroon","year":"2018","unstructured":"Haroon E, et al. Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder. Psychoneuroendocrinology. 2018;95:43\u20139.","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"1509_CR50","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12974-018-1163-z","volume":"15","author":"C Huang","year":"2018","unstructured":"Huang C, et al. Evidence of the impact of systemic inflammation on neuroinflammation from a non-bacterial endotoxin animal model. J Neuroinflammation. 2018;15(1):147.","journal-title":"J Neuroinflammation"},{"issue":"1-2","key":"1509_CR51","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jns.2008.10.022","volume":"277","author":"X Huang","year":"2009","unstructured":"Huang X, et al. GM-CSF inhibits glial scar formation and shows long-term protective effect after spinal cord injury. J Neurol Sci. 2009;277(1-2):87\u201397.","journal-title":"J Neurol Sci"},{"issue":"8","key":"1509_CR52","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1096\/fj.05-4382fje","volume":"20","author":"D Bouhy","year":"2006","unstructured":"Bouhy D, et al. Delayed GM-CSF treatment stimulates axonal regeneration and functional recovery in paraplegic rats via an increased BDNF expression by endogenous macrophages. Faseb j. 2006;20(8):1239\u201341.","journal-title":"Faseb j"},{"issue":"1","key":"1509_CR53","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.nbd.2011.02.011","volume":"43","author":"EN Mangano","year":"2011","unstructured":"Mangano EN, et al. Granulocyte macrophage-colony stimulating factor protects against substantia nigra dopaminergic cell loss in an environmental toxin model of Parkinson\u2019s disease. Neurobiology of Disease. 2011;43(1):99\u2013112.","journal-title":"Neurobiology of Disease"},{"issue":"4","key":"1509_CR54","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.4049\/jimmunol.1500861","volume":"195","author":"HM Mehta","year":"2015","unstructured":"Mehta HM, Malandra M, Corey SJ. G-CSF and GM-CSF in Neutropenia. Journal of immunology (Baltimore, Md. : 1950). 2015;195(4):1341\u20139.","journal-title":"Journal of immunology (Baltimore, Md. : 1950)"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-019-1509-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-019-1509-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-019-1509-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T03:45:46Z","timestamp":1694922346000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-019-1509-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1509"],"URL":"https:\/\/doi.org\/10.1186\/s12974-019-1509-1","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,1]]},"assertion":[{"value":"13 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the experiments were in accordance with the guidelines of Tehran University of Medical Sciences and approved by the Animal Ethics Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"117"}}